Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

Medical - Diagnostics & Research

Healthcare
$1.59 +2.44%

+$0.13 today

Market cap
$52.08M
Beta
1.79
P/E (TTM)
-3.9
EPS (TTM)
-$1.39
52W Low $2.33High $8.51

Volume 0.64M

Average 0.38M

Price history

Insight Molecular Diagnostics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-74.88%

Period high

$7.50

Period low

$1.59

Latest

$1.59

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KSep 21, 2026Sep 21, 2026
10-QAug 10, 2026Aug 10, 2026
8-KAug 10, 2026Aug 10, 2026
S-8Jul 24, 2026Jul 24, 2026
4Jul 6, 2026Jul 6, 2026
4Jul 6, 2026Jul 6, 2026
4Jul 6, 2026Jul 6, 2026
8-KJun 17, 2026Jun 17, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
8-KMay 13, 2026May 13, 2026
10-QMay 13, 2026May 13, 2026
8-K/AMay 13, 2026May 13, 2026
ARSApr 30, 2026Apr 30, 2026

Competitors

Who does Insight Molecular Diagnostics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IMDX's filings, answered from its disclosures.

What is the latest IMDX filing?

The latest filing shown is 8-K dated Sep 21, 2026.

How many recent filings does IMDX have?

Intrinsic Alpha currently shows 20 recent filings for IMDX.